DCF — ST. ELIZABETH MEDICAL CENTER
Enterprise Value: $-300.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-300.0M
Enterprise Value
$-96.2M
PV of Cash Flows
$-203.8M
PV of Terminal Value
$-328.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $225.9M | $-18.0M | -8.0% | $-27.6M | $-25.0M |
| Year 2 | $232.7M | $-16.2M | -7.0% | $-26.1M | $-21.5M |
| Year 3 | $239.7M | $-14.3M | -6.0% | $-24.4M | $-18.4M |
| Year 4 | $246.9M | $-13.5M | -5.0% | $-23.9M | $-16.3M |
| Year 5 | $254.3M | $-13.3M | -5.0% | $-24.0M | $-14.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-300.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$219.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08461342426528091
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5